Slide 1: Where Telehealth Stops, We Go
© 2021 All Rights Reserved – DocGo Investor Presentation February 2021 INVESTOR PRESENTATION MARCH 8 2021 WHERE TELEHEALTH STOPS, WE GO
Slide 2: Disclaimer
© 2021 All Rights Reserved – DocGo Disclaimer This presentation is contemplates a business combination pursuant to an merger agreement, by and among Ambulnz Inc. (dba “Doc Go” ), Motion Acquisition Corp. (“Motion”), and a wholly owned subsidiary of Motion, dated as of March ___, 2021. This presentat
Slide 3: Disclaimer (cont'd)
© 2021 All Rights Reserved – DocGo Disclaimer (cont’d) Market and Industry Data Market data and industry data used throughout this presentation is based on information derived from third party sources, the kn owledge of the management teams of Motion and DocGo regarding their respective industries a
Slide 4: Disclaimer (cont'd) Forward Looking Statements
© 2021 All Rights Reserved – DocGo Disclaimer (cont’d) Forward Looking Statements (cont’d) Any financial projections in this presentation are forward - looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyon
Slide 5: Key Highlights
© 2021 All Rights Reserved – DocGo 2019E 2020E 2021E 2022E $ 267 M $155M $94M $48M DocGo . All Systems Go. Key Highlights Steep Innovation and Revenue Growth Trajectory Rapidly expanding to meet the market need for a better way to deliver “last - mile” care Annual Revenue % growth 19 % 95 % 65% 72%
Slide 6: Experienced Management Team
© 2021 All Rights Reserved – DocGo Experienced Management Team Stan Vashovsky Co - Founder, Chief Executive Officer Andre Oberholzer Chief Financial Officer • Founded DocGo (f/k/a DocGo ) in 2015 with the vision to revolutionize medical transportation and healthcare delivery • Previously an executiv
Slide 7: Our Vision
© 2021 All Rights Reserved – DocGo Our Vision © 2021 All Rights Reserved – DocGo Care Logistics Network Proprietary Technology Platform TeleHealth Plus Distributed Workforce of Medical Professionals Fulfilling the Promise of Telehealth by Enabling the “Last - Mile” Delivery of Healthcare The global
Slide 8: Significant Market Opportunity
© 2021 All Rights Reserved – DocGo Significant Market Opportunity U.S. Total Addressable Market Source: McKinsey “Telehealth: A quarter - trillion - dollar - post - COVID - 19 reality” report published 5/1/20 and management estimates. $95 billion market opportunity leaving long runway for rapid grow
Slide 9: Today's Healthcare Has Acute Pain Points
© 2021 All Rights Reserved – DocGo Today’s Healthcare Has Acute Pain Points Telemedicine’s lack of physical interaction limits its applicability and prevents broad and efficient adoption Delivery of care logistics is not fully integrated with core hospital / clinic operations, resulting in inefficie
Slide 10: Network Effect Drives Efficiencies of Scale
© 2021 All Rights Reserved – DocGo Network Effect Drives Efficiencies of Scale (a) May enter certain markets before ambulance operations, based on consumer demand . Highly replicable go - to - market strategy Develop JV / Heal th System Relationship Identify attractive, high - growth market and deve
Slide 11: Our Brand and Company Culture
© 2021 All Rights Reserved – DocGo Our Brand and Company Culture © 2021 All Rights Reserved – DocGo is now Where basic telehealth providers stop, we go. Where mass testing needs to be administered, we go. Where homebound populations benefit from onsite treatment, we go. Where long waits in busy emer
Slide 12: Our Integrated Technology Platform
© 2021 All Rights Reserved – DocGo Our Integrated Technology Platform Our digital platform is fully integrated with industry standard EHR providers and enables a seamless care logistics experience throughout the patient journey Multi - modal Software to Better Coordinate Care Modern Architecture and
Slide 13: For Patients… For Providers…
© 2021 All Rights Reserved – DocGo For Patients… ✓ At home treatment is convenient, comfortable and results in an improved patient experience ✓ Accessibility to health professionals promotes better patient compliance with discharge treatment plans ✓ More focused care reduces unnecessary hospital rea
Slide 14: Differentiated Approach Creates Efficiency and Cost Savings
© 2021 All Rights Reserved – DocGo Differentiated Approach Creates Efficiency and Cost Savings Vaccination Bloodwork IV Hydration Wound Care Oral Medicine Administration EKG DocGo Industry Average Enabling Dramatic TeleHealth Plus Cost Advantage • Compelling unit cost economics ▪ Cash break - even i
Slide 15: Innovative Mobility Solution Driving Patient Satisfaction and Quality
© 2021 All Rights Reserved – DocGo Innovative Mobility Solution Driving Patient Satisfaction and Quality Fully integrated solution provider facilitating high - quality, efficient patient transportation across all sites of care Pediatrics / Neonatal Intensive Care Unit Critical Care Transport Car Whe
Slide 16: Delivering Value Across the Healthcare Ecosystem
© 2021 All Rights Reserved – DocGo Delivering Value Across the Healthcare Ecosystem Providers x Superior service x Economic value proposition Patients x More convenient x Better experience Payers x Lower cost x Members access cost - effective care Healthcare Professionals x More satisfaction x Bette
Slide 17: Our Footprint and Reach
© 2021 All Rights Reserved – DocGo Our Footprint and Reach Our Footprint Operating in 23 states and the UK Licensed to operate in 29 states; licenses pending in 14 additional states <1% market penetration today TeleHealth Plus Only Mobility and TeleHealth Plus Mobility Only 16
Slide 18: Key Relationships & Partners
© 2021 All Rights Reserved – DocGo Key Relationships & Partners World Class Partners and Joint Ventures Purpose - built network to revolutionize healthcare delivery and logistics TeleHealth Plus Relationships 17
Slide 19: JV Partners Help Drive Predictable Growth
© 2021 All Rights Reserved – DocGo JV Partners Help Drive Predictable Growth Highly recurring and predictable revenue National footprint across JVs Evergreen contract structure with multi - year cancellation notice period $500M+ per year combined revenue opportunity (b) DocGo is in advanced talks wi
Slide 20: Key Takeaways
© 2021 All Rights Reserved – DocGo Key Takeaways Significant market and growth opportunity with limited current market penetration Early stages of accelerating recurring revenue growth Unique value proposition to healthcare systems and patients Defensible competitive advantages in technology / netwo
Slide 21: Financial Overview
> Financial Overview
Slide 22: Highly Attractive Financial Characteristics
© 2021 All Rights Reserved – DocGo Highly Attractive Financial Characteristics Significant revenue growth opportunity with limited existing penetration Embedded visibility into recurring revenue growth within existing joint venture partnerships Scalable business model with robust operating leverage
Slide 23: Recurring, Predictable Revenue Model
© 2021 All Rights Reserved – DocGo Recurring, Predictable Revenue Model • Data - driven market - by - market approach to identify highly visible, recurring transportation needs by provider • Base rate and average transport distance largely dependent upon geography • Base rate typically references a
Slide 24: Strong Growth Trajectory and Margin Profile
© 2021 All Rights Reserved – DocGo ($34) ($18) ($6) $5 $38 2018E 2019E 2020E 2021E 2022E $8 $13 $32 $65 $117 2018E 2019E 2020E 2021E 2022E ($31) ($17) ($6) $6 $43 2018E 2019E 2020E 2021E 2022E Strong Growth Trajectory and Margin Profile Revenue Gross Profit 28.5% 21.4% 95.3% 64.6% 71.7% 20.8% 27.3%
Slide 25: Attractive Reimbursement Mechanisms & Payer Mix
© 2021 All Rights Reserved – DocGo Attractive Reimbursement Mechanisms & Payer Mix • Significant relationships with municipalities support a stable payer profile • Established Medicare fee schedules provide visibility & predictability into expected payment across the majority of the business • Contr
Slide 26: Operating Leverage Drives Significant Productivity Improvement
© 2021 All Rights Reserved – DocGo Fuel / Maintenance 6.4% Billing 3.8% Medical Supplies 0.3% Dispatch 3.2% Labor Cost 66.3% Lease 5.4% Other 14.6% Variable Fixed • More than 85% of unit cost base has fixed characteristics • This implies significant leverage to productivity improvements via rides pe
Slide 27: Transaction Overview
> Transaction Overview
Slide 28: Estimated Transaction Sources & Uses
© 2021 All Rights Reserved – DocGo Estimated Transaction Sources & Uses Post - Money Valuation at Close Illustrative Post - Transaction Ownership (b) ($ in millions) ($ in millions) Sources Uses SPAC Cash in Trust $115 PIPE Investor Cash $125 Total Sources $240 Cash to Balance Sheet $205 Transaction
Slide 29: Comparable Company Benchmarking
© 2021 All Rights Reserved – DocGo DocGo Healthcare Peers Virtual Care Peers Peer Group Average 2019A - 2022E Revenue CAGR 2021E Gross Profit Margin 2019A - 2022E Gross Profit CAGR 107% 96% 30% 32% 53% 57% 25% 49% DocGo Oak Street One Medical Accolade Teladoc Hims&Hers AmWell Peer Group Average 77%
Slide 30: Comparable Company Benchmarking (cont'd)
© 2021 All Rights Reserved – DocGo DocGo Healthcare Peers Virtual Care Peers Peer Group Median EV/2021E Revenue EV/2021E Gross Profit EV/2022E Revenue EV/2022E Gross Profit 5.8x 9.4x 10.7x 11.5x 17.8x 16.9x 20.3x 14.2x DocGo Oak Street One Medical Accolade Teladoc Hims&Hers AmWell Peer Group Median
Slide 31: Appendices
> Appendices
Slide 32: Integrated Solutions Drive Competitive Advantage and Superior Go To Market Strategy
© 2021 All Rights Reserved – DocGo ~40%+ Mobility Only Integrated Solutions Drive Competitive Advantage and Superior Go To Market Strategy Common Technology Platform Holistic Solution for Providers, Patients and Payers LONG TERM, EXCLUSIVE CONTRACTS GEOGRAPHIC DENSITY SCALABLE INFRASTRUCTURE LEVERAG
Slide 33: Pro Forma Adjusted EBITDA Reconciliation
© 2021 All Rights Reserved – DocGo Pro Forma Adjusted EBITDA Reconciliation CY2020E Net Loss Attributable to Ambulnz ($9,497) (+) Loss of JV (260) Net Loss (GAAP) ($9,757) (+) Net Interest Expense / (Income) (243) (+) Income Tax 35 (+) Depreciation & Amortization 2,029 (+) Leased Vehicles + Gurneys
Slide 34: Historical & Projected Financial Summary
© 2021 All Rights Reserved – DocGo ($ millions) 2018E 2019E (a) 2020E (a) 2021E 2022E Revenue $40 $48 $94 $155 $267 % growth 28.5% 21.4% 95.3% 64.6% 71.7% Gross Profit $8 $13 $32 $65 $117 % margin 20.8% 27.3% 33.9% 41.7% 44.0% Adjusted EBITDA ($31) ($17) ($6) $6 $43 % margin NM NM NM 3.9% 16.1% Net
Slide 35: Biography
© 2021 All Rights Reserved – DocGo Biography Previous Experience • Over 30 years of technology industry experience in global software services • Veteran Telematics professional with over 33 years industry experience and successful track record in transportation software and technology end market spa
Slide 36: Investment Highlights
© 2021 All Rights Reserved – DocGo Investment Highlights Innovative digital - first medical mobility pioneer reimagining traditional care delivery Bridging the gap between physical and virtual care with telehealth fulfillment solutions Significant, untapped TAM opportunity across current markets and